Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes Eric Schmidt.

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...

Something strange has been happening with biotech stocks over the past few weeks: They have been going up. The SPDR S&P Biotech ETF, a benchmark for the sector, closed April 8 at $69.80, its worst ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 million EC and U.S. FDA label updates for CARVYKTI ® to include overall survival benefit versus standard of care ...

Exceeded 10,000 patients treated to date with CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) Increased CARVYKTI ® manufacturing capacity with the physical expansion of the Raritan facility, now the ...

The following medical device manufacturer and biotech mergers occurred in the past two months. 1. In two days, Minneapolis-based Medtronic announced two acquisition deals. In the first deal, Medtronic ...